carbon monoxide has been researched along with Hypocapnia in 3 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Hypocapnia: Clinical manifestation consisting of a deficiency of carbon dioxide in arterial blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " They had an unusual pattern of cardiopulmonary abnormalities with mild to moderate airway obstruction, severe hypoxemia, hypocapnia, and a very low diffusing capacity for carbon monoxide (p < 0." | 3.73 | Severe pulmonary hypertension and chronic obstructive pulmonary disease. ( Bugnet, AS; Chaouat, A; Ducoloné, A; Ehrhart, M; Enache, I; Kadaoui, N; Kessler, R; Schott, R; Weitzenblum, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaouat, A | 1 |
| Bugnet, AS | 1 |
| Kadaoui, N | 1 |
| Schott, R | 1 |
| Enache, I | 1 |
| Ducoloné, A | 1 |
| Ehrhart, M | 1 |
| Kessler, R | 1 |
| Weitzenblum, E | 1 |
| Benignus, VA | 1 |
| Upton, RN | 1 |
| Ludbrook, GL | 1 |
| Grant, C | 1 |
| Martinez, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronisch Obstruktive Lungenerkrankung Und Pulmonale Hypertonie: Prävalenz Und Lebensqualität[NCT01423071] | 220 participants (Actual) | Observational | 2011-08-31 | Completed | |||
| A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)[NCT01725256] | Phase 2 | 29 participants (Actual) | Interventional | 2012-11-30 | Terminated (stopped due to Terminated early dt to acquisition of Sponsor and change in corporate priorities) | ||
| A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension[NCT01725269] | Phase 2 | 17 participants (Actual) | Interventional | 2013-03-31 | Terminated (stopped due to Terminated early dt acquisition of Sponsor and change in corporate priorities) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carbon monoxide and Hypocapnia
| Article | Year |
|---|---|
Behavioral effects of carbon monoxide: meta analyses and extrapolations.
Topics: Animals; Behavior; Behavior, Animal; Body Temperature; Carbon Monoxide; Carboxyhemoglobin; Dose-Resp | 1994 |
2 other studies available for carbon monoxide and Hypocapnia
| Article | Year |
|---|---|
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Severe pulmonary hypertension and chronic obstructive pulmonary disease.
Topics: Aged; Airway Obstruction; Blood Pressure; Carbon Monoxide; Case-Control Studies; Dyspnea; Heart; Hum | 2005 |
Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration.
Topics: Adrenergic alpha-Agonists; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenou | 1999 |